Search
Now showing items 11-20 of 20
Article
Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens
| Date Issued:
2012 | Copyright:
open access
Article
Chagasic Patients with Indeterminate Clinical Form of the Disease have High Frequencies of Circulating CD3 Þ CD16 –CD56 þNatural Killer T Cells and CD4 þ CD25 High Regulatory T Lymphocytes
| Date Issued:
2005 | Copyright:
restricted access
Article
Trypanosoma cruzi: Desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
| Date Issued:
2011 | Copyright:
restricted access
Article
Phenotypic Features of Circulating Leukocytes from Non-human Primates Naturally Infected with Trypanosoma cruzi Resemble the Major Immunological Findings Observed in Human Chagas Disease
| Date Issued:
2016 | Copyright:
open access
Article
Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis
| Date Issued:
2013 | Copyright:
open access
Article
17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children
| Date Issued:
2012 | Copyright:
open access
Article
Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity
| Date Issued:
2018 | Copyright:
open access
Article
Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease
| Date Issued:
2010 | Copyright:
open access
Article
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults
| Date Issued:
2011 | Copyright:
restricted access
Article
Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination
| Date Issued:
2010 | Copyright:
restricted access